Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Edge Therapeutics reverse merges with PDS Biotechnology

Executive Summary

Public Edge Therapeutics Inc. agreed to merge with privately held immunotherapy firm PDS Biotechnology Corp. in a stock-for-stock transaction.
Deal Industry
  • Biotechnology
    • Large Molecule
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Reverse Acquisition
    • Includes Contract
    • Intra-Biotech Deal
    • Full Acquisition
    • Acquisition of Private Biotech

Related Companies

Advertisement
UsernamePublicRestriction

Register